Beijing Jiyin Medical Technology Co., Ltd., established on 2021-12-20, Business scope includes technology development,Technical Services,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Medical Research and Experimental Development;medical service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Medical services and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

BioArctic is a Swedish research-oriented biopharma company. The company was founded in 2003 by Professor Lars Lannfelt and Dr. Pär Gellerfors to develop important breakthrough discoveries made by Professor Lannfelt regarding Alzheimer’s disease. These discoveries – the Swedish mutation and the Arctic mutation – have attracted much attention internationally and explain the central role of amyloid-beta in Alzheimer’s disease, which has led to the development of new treatment strategies. BioArctic has developed a proprietary technology platform that has proven to be successful when the company’s first drug candidate antibody BAN2401 for Alzheimer´s disease was developed. The company’s technology is now also used for other diseases of the Central Nervous System such as Parkinson’s disease (BioArctic’s antibody BAN0805) and also for related diagnostics and technology.

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the dna.

EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Guangzhou Junhe Biotechnology Co., Ltd., established on 2012-02-22, Business scope includes computer technology development,Technical Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;

KingMed Diagnostics provides medical facilities with outsourced medical examination and pathology diagnosis services. Its offerings include mass spectrometry, inspection, pathology diagnosis, immunology testing, biochemical luminescence testing, genetic testing, physical and chemical testing, and pathology diagnosis.

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

Beijing Mygenostics Co., Ltd. is a Chinese company located in Beijing that operates as an biotechnology company that provides life science instruments, reagents and technical services.

3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable for patients in need. The company was established in 2016 and is headquartered in Seoul, South Korea.

Guangzhou Kingmed Center For Clinical Laboratory Co., Ltd. provides clinical and laboratory testing services. It offers clinical trials, medical examination, food and hygiene testing, physical examination, scientific research services, and quality management. The company was founded by YaoMing Liang in 1994 and is headquartered in Guangzhou, China.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

Wankangyuan (Tianjin) Gene Technology Co., Ltd., established on 2015-01-06, The business scope includes genetic medicine related equipment and electronic products,Technology development of computer hardware and software,transfer,Consulting and Services;Health Information Consultation(Except for medical advice);biotechnology development,Technical Services,technology transfer,technical consulting;Conference Services;Exhibition;Computer System Services;Computer hardware and software and auxiliary equipment,Equipment,Instrumentation,Chemical Products(Hazardous chemicals and precursor drugs are excluded),Wujinjiaodian,Machinery sales;Goods and technology import and export business;Pharmaceutical Technology Development,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

École nationale vétérinaire de Toulouse (National Veterinary School of Toulouse, ENVT), is a veterinary school located in Toulouse, France. Established in 1825, it is also an institution of higher education and research and a teaching hospital.

Shanghai Angpu Biotechnology Co., Ltd., established on 2013-09-27, Business scope includes licensed projects:Production of Class III Medical Devices;Production of Class II Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology,Technology development in the field of computer science and technology,technical consulting,Technical Services,technology transfer,computer software development,Engineering and Technology Research and Experimental Development,experiment apparatus,equipment,Class I medical device,Class II medical device,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of,Import and export,Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)